EU proposals address some of Clinical Trials Directive's shortcomings
This article was originally published in Scrip
Executive Summary
The European Commission is proposing revisions to its guidance on the reporting of adverse events arising from clinical trials, as a "short-term" fix of the many concerns raised by stakeholders with regard to the present clinical trials framework in the European Union.